
    
      Constitution of a prospective cohort of 128 patients with 8 different groups of patients.
      This protocol is designed to evaluate a new tool for detecting the diversity of the
      repertoire T and B in patients with hematological disease. This in vitro diagnostic device is
      consisting of molecular biology kits Human ImmunTraCkeR® and Human Immun'IgH® and the
      analysis tool NDL®
    
  